ArticleCurrent oncology (Toronto, Ont.)2025

Pemigatinib in the Real-World Management of Cholangiocarcinoma Through a Canadian Patient Support Program.

Philip Q Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.